Lancets Market 2025 Booming Worldwide with Latest Trend and Future Scope by 2031 | Roche, Lifescan, BD, MTD Group, Greiner Bio One

Los Angeles, United States - QY Research has unveiled its latest study titled "Global Lancets Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This newly released report delivers a comprehensive overview of the global Lancets market, analyzing the forces shaping its growth trajectory and providing valuable insights for stakeholders, investors, and industry professionals.

The global market for Lancets was estimated to be worth US$ 1673 million in 2024 and is forecast to a readjusted size of US$ 2056 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.

The research covers key areas including market dynamics, segmentation, regional performance, competitive landscape, and emerging technology trends that are redefining industry standards. Backed by reliable data and expert analysis, the report serves as a trusted guide to understanding both microeconomic and macroeconomic factors driving market evolution.

Download Free Sample PDF Report (with full TOC, tables, and charts) To Explore Detailed Insights and Forecasts @ https://qyresearch.in/request-sample/pharma-healthcare-global-lancets-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The research report also includes the global Lancets market figures that provide historical data as well as estimated figures. It gives a clear picture of the growth rate of the market during the forecast period. The Lancets report aims to give the readers quantifiable data that is collected from verified data. The report attempts to answer all the difficult questions such as market sizes and company strategies.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Lancets cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylkettonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.In 2024, global Lancets production reached approximately 55.37 billion units, with an average global market price of around 30.22 US$ / k unit.

Competitive Landscape: -

Roche
Lifescan
BD
MTD Group
Greiner Bio One
Owen Mumford
Cardinal Health
Ascensia
Abbott
B. Braun
Terumo
I-SENS
Nipro
ICU Medical
Sarstedt
Sinocare
Yueyue Medical
Tianjin Huahong Medical
Suzhou Shilai Medical
Shandong Lianfa Medical
Promisemed

The competitive landscape is a must-have information for the market players to withstand the competition present in the global Lancets market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Lancets market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

Market Drivers:

Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.

Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.

Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.

Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.

Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.

Market Challenges:

Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.

High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.

Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.

Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.

Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.

Regional Insights -

The report takes readers on a journey through four key regions: United States, Asia-Pacific, and EMEA. Key nations like the United States, Germany, the United Kingdom, China, Japan, South Korea, and more are thoroughly examined. The data is presented in a timeline from 2024 as the base year, with projections extending to 2031.

North America: United States, Canada, Mexico

Latin America: Brazil and other key markets

Asia Pacific: China, Japan, South Korea, India, ASEAN countries

Europe, Middle East & Africa (EMEA): Major European economies, GCC countries, and African nations

The report provides a region-wise breakdown of market share, consumption trends, and future prospects.

Detailed of Lancets Market Segmentation -

The report offers great insights into important segments of the global Lancets market while concentrating on their CAGR, market size, market share, and future growth potential. The global Lancets market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Lancets market.

Segmentation By Type :-

Safety Lancets
Ordinary Lancets

Segmentation By Application -

Blood Glucose Test
Newborn Screening
Rapid Blood Test
Other

This segmentation helps identify high-growth opportunities and niche segments for investors and businesses.

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/pharma-healthcare-global-lancets-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report is a Must-Have -

ᗒ Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

ᗒ Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

ᗒ Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

ᗒ Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

ᗒ Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Lancets Market Report Objectives -

(1) Analyzing the size of the global Lancets market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Lancets market

(3) Exploring key dynamics of the global Lancets market

(4) Highlighting important trends of the global Lancets market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Lancets market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Lancets market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Important Questions Answered included in the Report:-

(A) What is the market size and growth rate of the global and regional market by various segments?

(B) What is the market size and growth rate of the market for selective Countries?

(C) Which region or sub-segment is expected to drive the market in the forecast period?

(D) What factors are estimated to drive and restrain the market growth?

(E) What are the key technology and market trends shaping the market?

(F) what are the key opportunity in the market?

(G) Who are the leading manufacturers operating in the global Lancets market?

(H) Which key player accounted for the highest market share?

(I) What are the growth opportunities for the new entrants in the global Lancets market?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Lancets Product Introduction
1.2 Global Lancets Market Size Forecast
1.2.1 Global Lancets Sales Value (2020-2031)
1.2.2 Global Lancets Sales Volume (2020-2031)
1.2.3 Global Lancets Sales Price (2020-2031)
1.3 Lancets Market Trends & Drivers
1.3.1 Lancets Industry Trends
1.3.2 Lancets Market Drivers & Opportunity
1.3.3 Lancets Market Challenges
1.3.4 Lancets Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lancets Players Revenue Ranking (2024)
2.2 Global Lancets Revenue by Company (2020-2025)
2.3 Global Lancets Players Sales Volume Ranking (2024)
2.4 Global Lancets Sales Volume by Company Players (2020-2025)
2.5 Global Lancets Average Price by Company (2020-2025)
2.6 Key Manufacturers Lancets Manufacturing Base and Headquarters
2.7 Key Manufacturers Lancets Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lancets
2.9 Lancets Market Competitive Analysis
2.9.1 Lancets Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Lancets Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety Lancets
3.1.2 Ordinary Lancets
3.2 Global Lancets Sales Value by Type
3.2.1 Global Lancets Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Lancets Sales Value, by Type (2020-2031)
3.2.3 Global Lancets Sales Value, by Type (%) (2020-2031)
3.3 Global Lancets Sales Volume by Type
3.3.1 Global Lancets Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Lancets Sales Volume, by Type (2020-2031)
3.3.3 Global Lancets Sales Volume, by Type (%) (2020-2031)
3.4 Global Lancets Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Glucose Test
4.1.2 Newborn Screening
4.1.3 Rapid Blood Test
4.1.4 Other
4.2 Global Lancets Sales Value by Application
4.2.1 Global Lancets Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Lancets Sales Value, by Application (2020-2031)
4.2.3 Global Lancets Sales Value, by Application (%) (2020-2031)
4.3 Global Lancets Sales Volume by Application
4.3.1 Global Lancets Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Lancets Sales Volume, by Application (2020-2031)
4.3.3 Global Lancets Sales Volume, by Application (%) (2020-2031)
4.4 Global Lancets Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Lancets Sales Value by Region
5.1.1 Global Lancets Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Lancets Sales Value by Region (2020-2025)
5.1.3 Global Lancets Sales Value by Region (2026-2031)
5.1.4 Global Lancets Sales Value by Region (%), (2020-2031)
5.2 Global Lancets Sales Volume by Region
5.2.1 Global Lancets Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Lancets Sales Volume by Region (2020-2025)
5.2.3 Global Lancets Sales Volume by Region (2026-2031)
5.2.4 Global Lancets Sales Volume by Region (%), (2020-2031)
5.3 Global Lancets Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Lancets Sales Value, 2020-2031
5.4.2 North America Lancets Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Lancets Sales Value, 2020-2031
5.5.2 Europe Lancets Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Lancets Sales Value, 2020-2031
5.6.2 Asia Pacific Lancets Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Lancets Sales Value, 2020-2031
5.7.2 South America Lancets Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lancets Sales Value, 2020-2031
5.8.2 Middle East & Africa Lancets Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lancets Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Lancets Sales Value and Sales Volume
6.2.1 Key Countries/Regions Lancets Sales Value, 2020-2031
6.2.2 Key Countries/Regions Lancets Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Lancets Sales Value, 2020-2031
6.3.2 United States Lancets Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Lancets Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Lancets Sales Value, 2020-2031
6.4.2 Europe Lancets Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Lancets Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Lancets Sales Value, 2020-2031
6.5.2 China Lancets Sales Value by Type (%), 2024 VS 2031
6.5.3 China Lancets Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Lancets Sales Value, 2020-2031
6.6.2 Japan Lancets Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Lancets Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Lancets Sales Value, 2020-2031
6.7.2 South Korea Lancets Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Lancets Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Lancets Sales Value, 2020-2031
6.8.2 Southeast Asia Lancets Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Lancets Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Lancets Sales Value, 2020-2031
6.9.2 India Lancets Sales Value by Type (%), 2024 VS 2031
6.9.3 India Lancets Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Roche Lancets Product Offerings
7.1.5 Roche Recent Development
7.2 Lifescan
7.2.1 Lifescan Company Information
7.2.2 Lifescan Introduction and Business Overview
7.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Lifescan Lancets Product Offerings
7.2.5 Lifescan Recent Development
7.3 BD
7.3.1 BD Company Information
7.3.2 BD Introduction and Business Overview
7.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BD Lancets Product Offerings
7.3.5 BD Recent Development
7.4 MTD Group
7.4.1 MTD Group Company Information
7.4.2 MTD Group Introduction and Business Overview
7.4.3 MTD Group Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 MTD Group Lancets Product Offerings
7.4.5 MTD Group Recent Development
7.5 Greiner Bio One
7.5.1 Greiner Bio One Company Information
7.5.2 Greiner Bio One Introduction and Business Overview
7.5.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Greiner Bio One Lancets Product Offerings
7.5.5 Greiner Bio One Recent Development
7.6 Owen Mumford
7.6.1 Owen Mumford Company Information
7.6.2 Owen Mumford Introduction and Business Overview
7.6.3 Owen Mumford Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Owen Mumford Lancets Product Offerings
7.6.5 Owen Mumford Recent Development
7.7 Cardinal Health
7.7.1 Cardinal Health Company Information
7.7.2 Cardinal Health Introduction and Business Overview
7.7.3 Cardinal Health Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Cardinal Health Lancets Product Offerings
7.7.5 Cardinal Health Recent Development
7.8 Ascensia
7.8.1 Ascensia Company Information
7.8.2 Ascensia Introduction and Business Overview
7.8.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Ascensia Lancets Product Offerings
7.8.5 Ascensia Recent Development
7.9 Abbott
7.9.1 Abbott Company Information
7.9.2 Abbott Introduction and Business Overview
7.9.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Abbott Lancets Product Offerings
7.9.5 Abbott Recent Development
7.10 B. Braun
7.10.1 B. Braun Company Information
7.10.2 B. Braun Introduction and Business Overview
7.10.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 B. Braun Lancets Product Offerings
7.10.5 B. Braun Recent Development
7.11 Terumo
7.11.1 Terumo Company Information
7.11.2 Terumo Introduction and Business Overview
7.11.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Terumo Lancets Product Offerings
7.11.5 Terumo Recent Development
7.12 I-SENS
7.12.1 I-SENS Company Information
7.12.2 I-SENS Introduction and Business Overview
7.12.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 I-SENS Lancets Product Offerings
7.12.5 I-SENS Recent Development
7.13 Nipro
7.13.1 Nipro Company Information
7.13.2 Nipro Introduction and Business Overview
7.13.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Nipro Lancets Product Offerings
7.13.5 Nipro Recent Development
7.14 ICU Medical
7.14.1 ICU Medical Company Information
7.14.2 ICU Medical Introduction and Business Overview
7.14.3 ICU Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 ICU Medical Lancets Product Offerings
7.14.5 ICU Medical Recent Development
7.15 Sarstedt
7.15.1 Sarstedt Company Information
7.15.2 Sarstedt Introduction and Business Overview
7.15.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Sarstedt Lancets Product Offerings
7.15.5 Sarstedt Recent Development
7.16 Sinocare
7.16.1 Sinocare Company Information
7.16.2 Sinocare Introduction and Business Overview
7.16.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Sinocare Lancets Product Offerings
7.16.5 Sinocare Recent Development
7.17 Yueyue Medical
7.17.1 Yueyue Medical Company Information
7.17.2 Yueyue Medical Introduction and Business Overview
7.17.3 Yueyue Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Yueyue Medical Lancets Product Offerings
7.17.5 Yueyue Medical Recent Development
7.18 Tianjin Huahong Medical
7.18.1 Tianjin Huahong Medical Company Information
7.18.2 Tianjin Huahong Medical Introduction and Business Overview
7.18.3 Tianjin Huahong Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Tianjin Huahong Medical Lancets Product Offerings
7.18.5 Tianjin Huahong Medical Recent Development
7.19 Suzhou Shilai Medical
7.19.1 Suzhou Shilai Medical Company Information
7.19.2 Suzhou Shilai Medical Introduction and Business Overview
7.19.3 Suzhou Shilai Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Suzhou Shilai Medical Lancets Product Offerings
7.19.5 Suzhou Shilai Medical Recent Development
7.20 Shandong Lianfa Medical
7.20.1 Shandong Lianfa Medical Company Information
7.20.2 Shandong Lianfa Medical Introduction and Business Overview
7.20.3 Shandong Lianfa Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Shandong Lianfa Medical Lancets Product Offerings
7.20.5 Shandong Lianfa Medical Recent Development
7.21 Promisemed
7.21.1 Promisemed Company Information
7.21.2 Promisemed Introduction and Business Overview
7.21.3 Promisemed Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Promisemed Lancets Product Offerings
7.21.5 Promisemed Recent Development
8 Industry Chain Analysis
8.1 Lancets Industrial Chain
8.2 Lancets Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lancets Sales Model
8.5.2 Sales Channel
8.5.3 Lancets Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.